Mumbai: BDR Pharmaceutical announced the launch of the first-of-its-kind generic drug, Zisavel Capsules, for the treatment of invasive aspergillosis and mucormycosis. Zisavel belongs to the family of ...

BDR Pharma company has introduced new medication, under the brand name BDENZA 160mg, at Rs 6,300 for a strip of seven tablets. BDR Pharmaceuticals has launched novel prostate cancer drug named ...

MUMBAI (Reuters) – BDR Pharmaceuticals said on Monday it has applied to India’s patent office for a compulsory license to sell a generic version of Bristol-Myers Squibb Co’s cancer drug dasatinib, ...

The drug is approved for use in combination with standard Daunorubicin and Cytarabine induction & high- dose Cytarabine consolidation chemotherapy BDR Pharma, one of India’s leading generic ...

Taking a significant step towards countering Covid-19 in India, drug major Mankind Pharma and leading generic pharmaceutical company BDR Pharmaceuticals launches oral anti-Covid pill Molulife ...

Mumbai: Pharmaceutical company BDR Pharma launched generic drug BIAPENEM which can be used to treat intra-abdominal infections, lower respiratory infections, or complicated urinary tract infections.

The product would be priced competitively and will be available in powder form in a sachet that can be consumed orally after being dissolved in water, the drug maker noted. (Representational image) ...

New Delhi, Aug 5 () Drug firm BDR Pharmaceuticals on Wednesday said it has launched its antiviral drug Favipiravir for the treatment of COVID-19 patients in India at a price of Rs 63 per tablet. The ...

MUMBAI (Reuters) - BDR Pharmaceuticals International Pvt Ltd has applied to the patents office, seeking permission to sell a generic version of Bristol-Myers Squibb Co's cancer drug, dasatinib, ...

MUMBAI (Reuters) - BDR Pharmaceuticals has applied to the patent office for a compulsory licence to sell a generic version of Bristol-Myers Squibb Co's cancer drug dasatinib, a BDR executive said on ...

NEW DELHI: BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose ...